BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19298141)

  • 1. Diagnostic and analytical mutation scanning of Cryptosporidium: utility and advantages.
    Jex AR; Gasser RB
    Expert Rev Mol Diagn; 2009 Mar; 9(2):179-85. PubMed ID: 19298141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptosporidium--biotechnological advances in the detection, diagnosis and analysis of genetic variation.
    Jex AR; Smith HV; Monis PT; Campbell BE; Gasser RB
    Biotechnol Adv; 2008; 26(4):304-17. PubMed ID: 18430539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution melting-curve (HRM) analysis for the diagnosis of cryptosporidiosis in humans.
    Pangasa A; Jex AR; Campbell BE; Bott NJ; Whipp M; Hogg G; Stevens MA; Gasser RB
    Mol Cell Probes; 2009 Feb; 23(1):10-5. PubMed ID: 19013516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation scanning-coupled tools for the analysis of genetic variation in Taenia and diagnosis - status and prospects.
    Gasser RB; Campbell BE; Jex AR
    Infect Genet Evol; 2009 Sep; 9(5):740-7. PubMed ID: 19454324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the genetic diversity within Cryptosporidium hominis and Cryptosporidium parvum from imported and autochtonous cases of human cryptosporidiosis by mutation scanning.
    Jex AR; Gasser RB
    Electrophoresis; 2008 Nov; 29(20):4119-29. PubMed ID: 18991263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and genotypic identification of Cryptosporidium from a broad range of host species by nonisotopic SSCP analysis of nuclear ribosomal DNA.
    Jex AR; Ryan UM; Ng J; Campbell BE; Xiao L; Stevens M; Gasser RB
    Electrophoresis; 2007 Aug; 28(16):2818-25. PubMed ID: 17702061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical and cost-effective mutation scanning-based approach for investigating genetic variation in Cryptosporidium.
    Jex AR; Whipp M; Campbell BE; Cacciò SM; Stevens M; Hogg G; Gasser RB
    Electrophoresis; 2007 Nov; 28(21):3875-83. PubMed ID: 17960838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive non-isotopic restriction endonuclease fingerprinting of nucleotide variability in the gp60 gene within Cryptosporidium species, genotypes and subgenotypes infective to humans, and its implications.
    Pangasa A; Jex AR; Nolan MJ; Campbell BE; Haydon SR; Stevens MA; Gasser RB
    Electrophoresis; 2010 May; 31(10):1637-47. PubMed ID: 20419704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools for investigating the environmental transmission of Cryptosporidium and Giardia infections in humans.
    Smith HV; Cacciò SM; Tait A; McLauchlin J; Thompson RC
    Trends Parasitol; 2006 Apr; 22(4):160-7. PubMed ID: 16503418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism in Cryptosporidium species: an update.
    Plutzer J; Karanis P
    Vet Parasitol; 2009 Nov; 165(3-4):187-99. PubMed ID: 19660869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling Cryptosporidium and Giardia epidemiology.
    Cacciò SM; Thompson RC; McLauchlin J; Smith HV
    Trends Parasitol; 2005 Sep; 21(9):430-7. PubMed ID: 16046184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cryptosporidium: a genus in revision. The situation in Spain].
    Navarro-i-Martinez L; del Águila C; Bornay-Llinares FJ
    Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):135-43. PubMed ID: 21354665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cryptosporidiosis: an emerging zoonosis].
    Del Coco VF; Córdoba MA; Basualdo JA
    Rev Argent Microbiol; 2009; 41(3):185-96. PubMed ID: 19831318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons.
    Cama VA; Ross JM; Crawford S; Kawai V; Chavez-Valdez R; Vargas D; Vivar A; Ticona E; Navincopa M; Williamson J; Ortega Y; Gilman RH; Bern C; Xiao L
    J Infect Dis; 2007 Sep; 196(5):684-91. PubMed ID: 17674309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cryptosporidium: phylogeny and taxonomy].
    Chacín-Bonilla L
    Invest Clin; 2007 Mar; 48(1):1-4. PubMed ID: 17432539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'.
    Savioli L; Smith H; Thompson A
    Trends Parasitol; 2006 May; 22(5):203-8. PubMed ID: 16545611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis.
    Cacciò SM; Pozio E
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):429-43. PubMed ID: 16771620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterisation of species and genotypes of Cryptosporidium and Giardia and assessment of zoonotic transmission.
    Xiao L; Fayer R
    Int J Parasitol; 2008 Sep; 38(11):1239-55. PubMed ID: 18479685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptosporidiosis outbreaks associated with recreational water use--five states, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(29):729-32. PubMed ID: 17657205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.